News

PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new ...
LEARN MORE:How to give a subcutaneous injection. Both syringes and insulin pens use a small needle to inject insulin into your body. There are pros and cons to each, and which one you ultimately ...
Inhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.
The "Hypodermic Syringes and Needles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Hypodermic ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices ... as conventional insulin regimens employing syringes. The published evidence ...
Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.
Long-acting insulin helps people with diabetes maintain normal blood sugar levels throughout the day. Unlike short-acting insulin, it never peaks, keeping an even sugar level in your blood.
Innovent Biologics (HKEX: 01801) has recently received approval for Sycume (teprotumumab biosimilar) to treat thyroid eye disease (TED) in China, making it the country’s first insulin-like growth ...
Nashik: Speaking in parliament on the alarming rate of children being diagnosed with Type 1 diabetes, minister Rajabhau Waje has demanded urgent steps.
Modern management options include: Multiple daily injections using insulin pens or syringes Insulin pump therapy delivering programmed amounts throughout the day Continuous glucose monitoring ...